MARKET

RARE

RARE

Ultragenyx Pharm
NASDAQ
23.21
-0.99
-4.09%
After Hours: 23.80 +0.59 +2.54% 19:58 01/08 EST
OPEN
24.30
PREV CLOSE
24.20
HIGH
25.10
LOW
22.92
VOLUME
2.68M
TURNOVER
--
52 WEEK HIGH
46.50
52 WEEK LOW
18.41
MARKET CAP
2.24B
P/E (TTM)
-3.9085
1D
5D
1M
3M
1Y
5Y
1D
Looking Into Ultragenyx Pharmaceutical Inc's Recent Short Interest
Benzinga · 17h ago
Ultragenyx price target lowered to $50 from $55 at Morgan Stanley
TipRanks · 19h ago
ULTRAGENYX PHARMACEUTICAL INC <RARE.O>: RBC CUTS TARGET PRICE TO $35 FROM $72
Reuters · 20h ago
U.S. RESEARCH ROUNDUP- Alcoa, BlackRock, Evercore
Reuters · 1d ago
Assessing Ultragenyx Pharmaceutical (RARE) Valuation After New DTX401 Filing And Setrusumab Phase 3 Results
Simply Wall St · 3d ago
Ultragenyx CFO Howard Horn Reports Sale of Common Shares
Reuters · 3d ago
Ultragenyx Pharma Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 3d ago
Ultragenyx Pharma Price Target Cut to $60.00/Share From $80.00 by HC Wainwright & Co.
Dow Jones · 3d ago
More
About RARE
Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company. The Company is focused on the identification, acquisition, development, and commercialization of novel products for the treatment of serious rare and ultrarare genetic diseases. Its therapies and clinical-stage pipeline consist of four product categories: biologics, small molecules, AAV gene therapy, and nucleic acid product candidates. Its four approved product candidates include Crysvita (burosumab) for the treatment of X-linked hypophosphatemia (XLH), and tumor-induced osteomalacia (TIO), Mepsevii (vestronidase alfa) for the treatment of mucopolysaccharidosis VII (MPSVII) or Sly Syndrome, Dojolvi (triheptanoin) for the treatment of long-chain fatty acid oxidation disorders (LC-FAOD), and Evkeeza (evinacumab) for the treatment of homozygous familial hypercholesterolemia (HoFH). Its clinical product candidates include DTX401, DTX301, UX701, UX143, UX111, and GTX-102. UX143 for the treatment of Osteogenesis Imperfecta.

Webull offers Ultragenyx Pharmaceutical Inc stock information, including NASDAQ: RARE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RARE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RARE stock methods without spending real money on the virtual paper trading platform.